Table of Content

1 HIV Drugs Market Overview
1.1 Product Overview and Scope of HIV Drugs
1.2 HIV Drugs Segment by Type
1.2.1 Global HIV Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Multi-Class Combination Products
1.2.3 Nucleoside Reverse Transcriptase Inhibitors
1.2.4 Non-Nucleoside Reverse Transcriptase Inhibitors
1.2.5 Protease Inhibitors
1.2.6 Fusion Inhibitors
1.2.7 Entry Inhibitors - CCR5 Co-Receptor Antagonist
1.2.8 HIV Integrase Strand Transfer Inhibitors
1.3 HIV Drugs Segment by Application
1.3.1 Global HIV Drugs Market Value by Application: (2024-2034)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Global HIV Drugs Market Size Estimates and Forecasts
1.4.1 Global HIV Drugs Revenue 2018-2034
1.4.2 Global HIV Drugs Sales 2018-2034
1.4.3 Global HIV Drugs Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 HIV Drugs Market Competition by Manufacturers
2.1 Global HIV Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global HIV Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global HIV Drugs Average Price by Manufacturers (2018-2023)
2.4 Global HIV Drugs Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of HIV Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of HIV Drugs, Product Type & Application
2.7 HIV Drugs Market Competitive Situation and Trends
2.7.1 HIV Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest HIV Drugs Players Market Share by Revenue
2.7.3 Global HIV Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 HIV Drugs Retrospective Market Scenario by Region
3.1 Global HIV Drugs Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global HIV Drugs Global HIV Drugs Sales by Region: 2018-2034
3.2.1 Global HIV Drugs Sales by Region: 2018-2023
3.2.2 Global HIV Drugs Sales by Region: 2024-2034
3.3 Global HIV Drugs Global HIV Drugs Revenue by Region: 2018-2034
3.3.1 Global HIV Drugs Revenue by Region: 2018-2023
3.3.2 Global HIV Drugs Revenue by Region: 2024-2034
3.4 North America HIV Drugs Market Facts & Figures by Country
3.4.1 North America HIV Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America HIV Drugs Sales by Country (2018-2034)
3.4.3 North America HIV Drugs Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe HIV Drugs Market Facts & Figures by Country
3.5.1 Europe HIV Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe HIV Drugs Sales by Country (2018-2034)
3.5.3 Europe HIV Drugs Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HIV Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific HIV Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific HIV Drugs Sales by Country (2018-2034)
3.6.3 Asia Pacific HIV Drugs Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America HIV Drugs Market Facts & Figures by Country
3.7.1 Latin America HIV Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America HIV Drugs Sales by Country (2018-2034)
3.7.3 Latin America HIV Drugs Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa HIV Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa HIV Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa HIV Drugs Sales by Country (2018-2034)
3.8.3 Middle East and Africa HIV Drugs Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global HIV Drugs Sales by Type (2018-2034)
4.1.1 Global HIV Drugs Sales by Type (2018-2023)
4.1.2 Global HIV Drugs Sales by Type (2024-2034)
4.1.3 Global HIV Drugs Sales Market Share by Type (2018-2034)
4.2 Global HIV Drugs Revenue by Type (2018-2034)
4.2.1 Global HIV Drugs Revenue by Type (2018-2023)
4.2.2 Global HIV Drugs Revenue by Type (2024-2034)
4.2.3 Global HIV Drugs Revenue Market Share by Type (2018-2034)
4.3 Global HIV Drugs Price by Type (2018-2034)
5 Segment by Application
5.1 Global HIV Drugs Sales by Application (2018-2034)
5.1.1 Global HIV Drugs Sales by Application (2018-2023)
5.1.2 Global HIV Drugs Sales by Application (2024-2034)
5.1.3 Global HIV Drugs Sales Market Share by Application (2018-2034)
5.2 Global HIV Drugs Revenue by Application (2018-2034)
5.2.1 Global HIV Drugs Revenue by Application (2018-2023)
5.2.2 Global HIV Drugs Revenue by Application (2024-2034)
5.2.3 Global HIV Drugs Revenue Market Share by Application (2018-2034)
5.3 Global HIV Drugs Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Corporation Information
6.1.2 Bristol-Myers Squibb Description and Business Overview
6.1.3 Bristol-Myers Squibb HIV Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bristol-Myers Squibb HIV Drugs Product Portfolio
6.1.5 Bristol-Myers Squibb Recent Developments/Updates
6.2 Gilead Sciences
6.2.1 Gilead Sciences Corporation Information
6.2.2 Gilead Sciences Description and Business Overview
6.2.3 Gilead Sciences HIV Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Gilead Sciences HIV Drugs Product Portfolio
6.2.5 Gilead Sciences Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Corporation Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline HIV Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 GlaxoSmithKline HIV Drugs Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson HIV Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Johnson & Johnson HIV Drugs Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck HIV Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Merck HIV Drugs Product Portfolio
6.5.5 Merck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HIV Drugs Industry Chain Analysis
7.2 HIV Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HIV Drugs Production Mode & Process
7.4 HIV Drugs Sales and Marketing
7.4.1 HIV Drugs Sales Channels
7.4.2 HIV Drugs Distributors
7.5 HIV Drugs Customers
8 HIV Drugs Market Dynamics
8.1 HIV Drugs Industry Trends
8.2 HIV Drugs Market Drivers
8.3 HIV Drugs Market Challenges
8.4 HIV Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global HIV Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global HIV Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global HIV Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global HIV Drugs Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global HIV Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global HIV Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global HIV Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market HIV Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of HIV Drugs, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of HIV Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of HIV Drugs, Product Type & Application
Table 12. Global Key Manufacturers of HIV Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global HIV Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global HIV Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global HIV Drugs Sales by Region (2018-2023) & (K Units)
Table 18. Global HIV Drugs Sales Market Share by Region (2018-2023)
Table 19. Global HIV Drugs Sales by Region (2024-2034) & (K Units)
Table 20. Global HIV Drugs Sales Market Share by Region (2024-2034)
Table 21. Global HIV Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global HIV Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global HIV Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global HIV Drugs Revenue Market Share by Region (2024-2034)
Table 25. North America HIV Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America HIV Drugs Sales by Country (2018-2023) & (K Units)
Table 27. North America HIV Drugs Sales by Country (2024-2034) & (K Units)
Table 28. North America HIV Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America HIV Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe HIV Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe HIV Drugs Sales by Country (2018-2023) & (K Units)
Table 32. Europe HIV Drugs Sales by Country (2024-2034) & (K Units)
Table 33. Europe HIV Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe HIV Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific HIV Drugs Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific HIV Drugs Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific HIV Drugs Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific HIV Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific HIV Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America HIV Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America HIV Drugs Sales by Country (2018-2023) & (K Units)
Table 42. Latin America HIV Drugs Sales by Country (2024-2034) & (K Units)
Table 43. Latin America HIV Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America HIV Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa HIV Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa HIV Drugs Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa HIV Drugs Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa HIV Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa HIV Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global HIV Drugs Sales (K Units) by Type (2018-2023)
Table 51. Global HIV Drugs Sales (K Units) by Type (2024-2034)
Table 52. Global HIV Drugs Sales Market Share by Type (2018-2023)
Table 53. Global HIV Drugs Sales Market Share by Type (2024-2034)
Table 54. Global HIV Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global HIV Drugs Revenue (US$ Million) by Type (2024-2034)
Table 56. Global HIV Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global HIV Drugs Revenue Market Share by Type (2024-2034)
Table 58. Global HIV Drugs Price (USD/Unit) by Type (2018-2023)
Table 59. Global HIV Drugs Price (USD/Unit) by Type (2024-2034)
Table 60. Global HIV Drugs Sales (K Units) by Application (2018-2023)
Table 61. Global HIV Drugs Sales (K Units) by Application (2024-2034)
Table 62. Global HIV Drugs Sales Market Share by Application (2018-2023)
Table 63. Global HIV Drugs Sales Market Share by Application (2024-2034)
Table 64. Global HIV Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global HIV Drugs Revenue (US$ Million) by Application (2024-2034)
Table 66. Global HIV Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global HIV Drugs Revenue Market Share by Application (2024-2034)
Table 68. Global HIV Drugs Price (USD/Unit) by Application (2018-2023)
Table 69. Global HIV Drugs Price (USD/Unit) by Application (2024-2034)
Table 70. Bristol-Myers Squibb Corporation Information
Table 71. Bristol-Myers Squibb Description and Business Overview
Table 72. Bristol-Myers Squibb HIV Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Bristol-Myers Squibb HIV Drugs Product
Table 74. Bristol-Myers Squibb Recent Developments/Updates
Table 75. Gilead Sciences Corporation Information
Table 76. Gilead Sciences Description and Business Overview
Table 77. Gilead Sciences HIV Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Gilead Sciences HIV Drugs Product
Table 79. Gilead Sciences Recent Developments/Updates
Table 80. GlaxoSmithKline Corporation Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline HIV Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. GlaxoSmithKline HIV Drugs Product
Table 84. GlaxoSmithKline Recent Developments/Updates
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson HIV Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Johnson & Johnson HIV Drugs Product
Table 89. Johnson & Johnson Recent Developments/Updates
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck HIV Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Merck HIV Drugs Product
Table 94. Merck Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. HIV Drugs Distributors List
Table 98. HIV Drugs Customers List
Table 99. HIV Drugs Market Trends
Table 100. HIV Drugs Market Drivers
Table 101. HIV Drugs Market Challenges
Table 102. HIV Drugs Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of HIV Drugs
Figure 2. Global HIV Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global HIV Drugs Market Share by Type in 2024 & 2034
Figure 4. Multi-Class Combination Products Product Picture
Figure 5. Nucleoside Reverse Transcriptase Inhibitors Product Picture
Figure 6. Non-Nucleoside Reverse Transcriptase Inhibitors Product Picture
Figure 7. Protease Inhibitors Product Picture
Figure 8. Fusion Inhibitors Product Picture
Figure 9. Entry Inhibitors - CCR5 Co-Receptor Antagonist Product Picture
Figure 10. HIV Integrase Strand Transfer Inhibitors Product Picture
Figure 11. Global HIV Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 12. Global HIV Drugs Market Share by Application in 2024 & 2034
Figure 13. Hospital Pharmacies
Figure 14. Retail Pharmacies
Figure 15. Online Pharmacies
Figure 16. Others
Figure 17. Global HIV Drugs Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 18. Global HIV Drugs Market Size (2018-2034) & (US$ Million)
Figure 19. Global HIV Drugs Sales (2018-2034) & (K Units)
Figure 20. Global HIV Drugs Average Price (USD/Unit) & (2018-2034)
Figure 21. HIV Drugs Report Years Considered
Figure 22. HIV Drugs Sales Share by Manufacturers in 2024
Figure 23. Global HIV Drugs Revenue Share by Manufacturers in 2024
Figure 24. The Global 5 and 10 Largest HIV Drugs Players: Market Share by Revenue in 2024
Figure 25. HIV Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 26. Global HIV Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 27. North America HIV Drugs Sales Market Share by Country (2018-2034)
Figure 28. North America HIV Drugs Revenue Market Share by Country (2018-2034)
Figure 29. U.S. HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Canada HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Europe HIV Drugs Sales Market Share by Country (2018-2034)
Figure 32. Europe HIV Drugs Revenue Market Share by Country (2018-2034)
Figure 33. Germany HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. France HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. U.K. HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Italy HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Russia HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Asia Pacific HIV Drugs Sales Market Share by Region (2018-2034)
Figure 39. Asia Pacific HIV Drugs Revenue Market Share by Region (2018-2034)
Figure 40. China HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Japan HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. South Korea HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. India HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Australia HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Taiwan HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Indonesia HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Thailand HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Malaysia HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Philippines HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Latin America HIV Drugs Sales Market Share by Country (2018-2034)
Figure 51. Latin America HIV Drugs Revenue Market Share by Country (2018-2034)
Figure 52. Mexico HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Brazil HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Argentina HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Middle East & Africa HIV Drugs Sales Market Share by Country (2018-2034)
Figure 56. Middle East & Africa HIV Drugs Revenue Market Share by Country (2018-2034)
Figure 57. Turkey HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 58. Saudi Arabia HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 59. U.A.E HIV Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 60. Global Sales Market Share of HIV Drugs by Type (2018-2034)
Figure 61. Global Revenue Market Share of HIV Drugs by Type (2018-2034)
Figure 62. Global HIV Drugs Price (USD/Unit) by Type (2018-2034)
Figure 63. Global Sales Market Share of HIV Drugs by Application (2018-2034)
Figure 64. Global Revenue Market Share of HIV Drugs by Application (2018-2034)
Figure 65. Global HIV Drugs Price (USD/Unit) by Application (2018-2034)
Figure 66. HIV Drugs Value Chain
Figure 67. HIV Drugs Production Process
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Distributors Profiles
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed